HMDBP07400 | Aminoadipate-semialdehyde synthase | A4D0W4 | AASS | 7q31.3 | Enzyme | Not Available |
HMDBP07718 | Glutamate receptor 2 | P42262 | GRIA2 | 4q32-q33 | Unknown | - Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
- Stein E, Cox JA, Seeburg PH, Verdoorn TA: Complex pharmacological properties of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subtypes. Mol Pharmacol. 1992 Nov;42(5):864-71. [PubMed:1279377 ]
- Henley JM, Jenkins R, Hunt SP: Localisation of glutamate receptor binding sites and mRNAs to the dorsal horn of the rat spinal cord. Neuropharmacology. 1993 Jan;32(1):37-41. [PubMed:7679210 ]
- Li F, Owens N, Verdoorn TA: Functional effects of mutations in the putative agonist binding region of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Mol Pharmacol. 1995 Jan;47(1):148-54. [PubMed:7838123 ]
|
HMDBP07845 | Glutamate [NMDA] receptor subunit 3A | Q8TCU5 | GRIN3A | 9q31.1 | Unknown | - Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
|
HMDBP08853 | N-acetylaspartyl-glutamate synthetase A | Q8IXN7 | RIMKLA | 1p34.2 | Unknown | Not Available |
HMDBP08854 | Beta-citryl-glutamate synthase B | Q9ULI2 | RIMKLB | 12p13.31 | Unknown | Not Available |
HMDBP08965 | Putative aspartate aminotransferase, cytoplasmic 2 | Q8NHS2 | GOT1L1 | 8p11.23 | Enzyme | Not Available |
HMDBP08968 | Kynurenine--oxoglutarate transaminase 3 | Q6YP21 | CCBL2 | 1p22.2 | Enzyme | - Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
|
HMDBP08982 | Aspartate aminotransferase | Q2TU84 | GIG18 | | Enzyme | - Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
|
HMDBP09342 | GGT7 protein | A0PJJ9 | GGT7 | 20q11.22 | Enzyme | Not Available |
HMDBP09343 | Gamma-glutamyltransferase 5 | P36269 | GGT5 | 22q11.23 | Enzyme | Not Available |
HMDBP09432 | Glutamyl aminopeptidase | Q07075 | ENPEP | 4q25 | Enzyme | - Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
- Tobe H, Kojima F, Aoyagi T, Umezawa H: Purification by affinity chromatography using amastatin and properties of aminopeptidase A from pig kidney. Biochim Biophys Acta. 1980 Jun 13;613(2):459-68. [PubMed:7448199 ]
- Acarturk F, Parlatan ZI, Saracoglu OF: Comparison of vaginal aminopeptidase enzymatic activities in various animals and in humans. J Pharm Pharmacol. 2001 Nov;53(11):1499-504. [PubMed:11732752 ]
- Sasaki M, Bosman BW, Tan PS: Comparison of proteolytic activities in various lactobacilli. J Dairy Res. 1995 Nov;62(4):601-10. [PubMed:8568030 ]
|
HMDBP10657 | Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial | Q9H0R6 | QRSL1 | 6q21 | Enzyme | Not Available |
HMDBP10658 | Aspartyl aminopeptidase | Q9ULA0 | DNPEP | 2q35 | Enzyme | - Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
- Watanabe J, Tanaka H, Akagawa T, Mogi Y, Yamazaki T: Characterization of Aspergillus oryzae aspartyl aminopeptidase expressed in Escherichia coli. Biosci Biotechnol Biochem. 2007 Oct;71(10):2557-60. Epub 2007 Oct 7. [PubMed:17928682 ]
|
HMDBP10860 | Metabotropic glutamate receptor 8 | O00222 | GRM8 | 7q31.3-q32.1 | Unknown | - Suzuki G, Kimura T, Satow A, Kaneko N, Fukuda J, Hikichi H, Sakai N, Maehara S, Kawagoe-Takaki H, Hata M, Azuma T, Ito S, Kawamoto H, Ohta H: Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl- 3,6-dihydropyridine-1(2H)-carboxamide (FTIDC). J Pharmacol Exp Ther. 2007 Jun;321(3):1144-53. Epub 2007 Mar 14. [PubMed:17360958 ]
- Morimoto R, Uehara S, Yatsushiro S, Juge N, Hua Z, Senoh S, Echigo N, Hayashi M, Mizoguchi T, Ninomiya T, Udagawa N, Omote H, Yamamoto A, Edwards RH, Moriyama Y: Secretion of L-glutamate from osteoclasts through transcytosis. EMBO J. 2006 Sep 20;25(18):4175-86. Epub 2006 Sep 7. [PubMed:16957773 ]
|
HMDBP10861 | Metabotropic glutamate receptor 4 | Q14833 | GRM4 | 6p21.3 | Unknown | - Suzuki G, Kimura T, Satow A, Kaneko N, Fukuda J, Hikichi H, Sakai N, Maehara S, Kawagoe-Takaki H, Hata M, Azuma T, Ito S, Kawamoto H, Ohta H: Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl- 3,6-dihydropyridine-1(2H)-carboxamide (FTIDC). J Pharmacol Exp Ther. 2007 Jun;321(3):1144-53. Epub 2007 Mar 14. [PubMed:17360958 ]
|
HMDBP10862 | Metabotropic glutamate receptor 7 | Q14831 | GRM7 | 3p26.1-p25.1 | Unknown | - Suzuki G, Kimura T, Satow A, Kaneko N, Fukuda J, Hikichi H, Sakai N, Maehara S, Kawagoe-Takaki H, Hata M, Azuma T, Ito S, Kawamoto H, Ohta H: Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl- 3,6-dihydropyridine-1(2H)-carboxamide (FTIDC). J Pharmacol Exp Ther. 2007 Jun;321(3):1144-53. Epub 2007 Mar 14. [PubMed:17360958 ]
|
HMDBP11741 | Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial | O43716 | GATC | 12q24.31 | Unknown | Not Available |
HMDBP11747 | Gamma-glutamyltranspeptidase 2 | P36268 | GGT2 | | Unknown | Not Available |
HMDBP11748 | Putative gamma-glutamyltranspeptidase 3 | A6NGU5 | GGT3P | | Unknown | Not Available |